US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medincell

34.39

0.0000

Volume:- -

Turnover:- -

Market Cap:1.14B

PE:-46.27

High:34.39

Open:34.39

Low:34.39

Close:34.39

52wk High:34.39

52wk Low:6.98

Shares:33.10M

Float Shares:20.90M

Volume Ratio:4.83

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7432

EPS(LYR):-0.6725

ROE:540.19%

ROA:-9.16%

PB:-31.45

PE(LYR):-51.14

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Medincell

Exchange:

EXPERT

Establishment Date:

2003

Employees:

145

Office Location:

3 Rue des Frères Lumière,Jacou,Languedoc-Roussillon,France

Website:

http://www.medincell.com

Zip Code:

34830

Phone:

33 4 67 02 13 67

Fax:

- -

Introduction:

MedinCell S.A. develops various therapeutic solutions in France. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension completed Phase III trial for use in the treatment of schizophrenia; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-TJK, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials, such as mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for use in organ transplant; mdc-WWM for contraception; mdc-STM for use in malaria; mdc-KPT for use in acute pain for pets; and mdc-IRM for use in neuroscience. The company was incorporated in 2003 and is based in Jacou, France.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MDCLF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCLF\",,,,,undefined,":{"symbol":"MDCLF","market":"US","secType":"STK","nameCN":"Medincell","latestPrice":34.39,"timestamp":1770411600000,"preClose":34.39,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":20901284,"shares":33102886,"eps":-0.743243,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:00:00 EST Delay","open":34.39,"high":34.39,"low":34.39,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.743243,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":34.39,"volumeRatio":4.8267440232842125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCLF\",,,,,undefined,":{"symbol":"MDCLF","floatShares":20901284,"roa":"-9.16%","roe":"540.19%","lyrEps":-0.672465,"volumeRatio":4.8267440232842125,"shares":33102886,"dividePrice":0,"high":34.39,"amplitude":0,"preClose":34.39,"low":34.39,"week52Low":6.9757,"pbRate":"-31.45","psRate":"29.70","week52High":34.39,"institutionHeld":0,"latestPrice":34.39,"eps":-0.743243,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.743243,"open":34.39,"prevYearClose":6.9757,"prevWeekClose":34.39,"prevMonthClose":34.39,"prevQuarterClose":6.9757,"fiveDayClose":34.39,"twentyDayClose":6.9757,"sixtyDayClose":6.9757},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCLF\",params:#limit:5,,,undefined,":[{"date":"2022-06-14","symbol":"MDCLF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1655193600000,"name":null,"time":"","dateTimestamp":1655179200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCLF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCLF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1765429200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6022073,"yearFounded":2003,"employeeNum":145,"address":"3 Rue des Frères Lumière,Jacou,Languedoc-Roussillon,France","zipCode":"34830","officePhone":"33 4 67 02 13 67"},"stockCompanyDetail":{"websiteUrl":"http://www.medincell.com","description":"MedinCell S.A. develops various therapeutic solutions in France. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension completed Phase III trial for use in the treatment of schizophrenia; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-TJK, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials, such as mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for use in organ transplant; mdc-WWM for contraception; mdc-STM for use in malaria; mdc-KPT for use in acute pain for pets; and mdc-IRM for use in neuroscience. The company was incorporated in 2003 and is based in Jacou, France.","exchange":"EXPERT","name":"Medincell","nameEN":"Medincell"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MDCLF\",market:\"US\",,,undefined,":null}}